Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.46M Buy
17,352
+8,981
+107% +$740K 0.71% 31
2025
Q2
$663K Sell
8,371
-137
-2% -$10.9K 0.33% 66
2025
Q1
$764K Buy
8,508
+112
+1% +$10.5K 0.4% 63
2024
Q4
$835K Sell
8,396
-388
-4% -$40K 0.43% 60
2024
Q3
$998K Buy
8,784
+423
+5% +$50.3K 0.51% 49
2024
Q2
$1.04M Sell
8,361
-514
-6% -$66.2K 0.55% 46
2024
Q1
$1.17M Sell
8,875
-196
-2% -$24.2K 0.61% 40
2023
Q4
$989K Buy
9,071
+39
+0.4% +$4.05K 0.54% 46
2023
Q3
$930K Sell
9,032
-1,224
-12% -$132K 0.56% 42
2023
Q2
$1.18M Sell
10,256
-375
-4% -$42.6K 0.67% 29
2023
Q1
$1.13M Sell
10,631
-4,075
-28% -$440K 0.62% 35
2022
Q4
$1.63M Sell
14,706
-122
-0.8% -$12.5K 1.03% 19
2022
Q3
$1.28M Buy
14,828
+243
+2% +$21.7K 0.91% 16
2022
Q2
$1.33M Sell
14,585
-107
-0.7% -$9.49K 0.85% 24
2022
Q1
$1.21M Buy
+14,692
New +$1.16M 0.68% 33
2017
Q3
Sell
-3,692
Closed -$226K 81
2017
Q2
$226K Buy
3,692
+2
+0.1% +$122 0.21% 69
2017
Q1
$224K Hold
3,690
0.22% 70
2016
Q4
$207K Hold
3,690
0.2% 74
2016
Q3
$220K Sell
3,690
-1,085
-23% -$63.4K 0.22% 65
2016
Q2
$262K Sell
4,775
-195
-4% -$10.4K 0.25% 70
2016
Q1
$251K Buy
4,970
+138
+3% +$6.76K 0.23% 64
2015
Q4
$244K Hold
4,832
0.24% 64
2015
Q3
$228K Sell
4,832
-210
-4% -$11.2K 0.21% 66
2015
Q2
$274K Hold
5,042
0.26% 61
2015
Q1
$277K Hold
5,042
0.28% 65
2014
Q4
$273K Buy
+5,042
New +$281K 0.25% 69

Other funds holding MRK

Donald L. Hagan LLC's MRK Position: Q3 2025 in Review

Donald L. Hagan LLC increased its Merck (MRK) stake by 107% in Q3 2025, buying an estimated $740K and bringing the position to 17,352 shares worth $1.46M. The position accounts for 0.71% of the portfolio, ranked #31.

Donald L. Hagan LLC first reported a position in MRK in Q4 2014 and has held it in 26 quarters since. The position peaked at $1.63M in Q4 2022. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Donald L. Hagan LLC held 17,352 shares of Merck worth $1.46M as of Q3 2025.
  • Donald L. Hagan LLC bought 8,981 Merck shares in Q3 2025, an estimated $740K.
  • Merck made up 0.71% of Donald L. Hagan LLC's portfolio in Q3 2025, its #31 holding.
  • Donald L. Hagan LLC first reported a position in Merck in Q4 2014 and has held it in 26 quarters since.
  • Donald L. Hagan LLC's Merck position peaked at $1.63M in Q4 2022.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Donald L. Hagan LLC's 13F filing for Q3 2025, filed 16 Oct 2025.